Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021 Article

Robins, HI, Won, M, Seiferheld, WF et al. (2006). Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-0021 . NEURO-ONCOLOGY, 8(1), 47-52. 10.1215/S1522851705000311

Open Access

cited authors

  • Robins, HI; Won, M; Seiferheld, WF; Schultz, CJ; Choucair, AK; Brachman, DG; Demas, WF; Mehta, MR

sustainable development goals

authors

publication date

  • January 1, 2006

webpage

published in

keywords

  • BRAIN-TUMORS
  • CELL-LINE
  • CHEMOTHERAPY
  • Clinical Neurology
  • INHIBITION
  • Life Sciences & Biomedicine
  • MALIGNANT GLIOMAS
  • Neurosciences & Neurology
  • Oncology
  • POSTOPERATIVE VENOUS THROMBOEMBOLISM
  • PROFILE
  • PROTEIN-KINASE-C
  • RADIOTHERAPY
  • Science & Technology
  • THERAPY
  • glioblastoma multiforme
  • radiation
  • tamoxifen

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 47

end page

  • 52

volume

  • 8

issue

  • 1